Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01710631Phase 3Completed
A Phase 3 trial of eszopiclone in Insomnia, sponsored by Sumitomo Pharma America. Started Feb 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01710631.